These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4554008)

  • 21. Conversion to sirolimus for chronic allograft dysfunction: long-term results confirm predictive value of proteinuria.
    Diekmann F; Budde K; Slowinski T; Oppenheimer F; Fritsche L; Neumayer HH; Campistol JM
    Transpl Int; 2008 Feb; 21(2):152-5. PubMed ID: 18005087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.
    Stephany BR; Boumitri M; Budev M; Alao B; Poggio ED
    J Heart Lung Transplant; 2009 Jun; 28(6):564-71. PubMed ID: 19481016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Mechanism of proteinuria: filtration and resorption of plasma proteins].
    Galaske RG
    Fortschr Med; 1983 Apr; 101(14):657-9. PubMed ID: 6852735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of antihypertensive agents on proteinuria and renal function.
    Maki DD; Ma JZ; Louis TA; Kasiske BL
    Arch Intern Med; 1995 May; 155(10):1073-80. PubMed ID: 7748051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
    Sarnak MJ; Levey AS; Schoolwerth AC; Coresh J; Culleton B; Hamm LL; McCullough PA; Kasiske BL; Kelepouris E; Klag MJ; Parfrey P; Pfeffer M; Raij L; Spinosa DJ; Wilson PW;
    Circulation; 2003 Oct; 108(17):2154-69. PubMed ID: 14581387
    [No Abstract]   [Full Text] [Related]  

  • 26. [Selectivity of urinary protein excretion in patients with chronic parenchymatous nephropathies].
    Rohrer T; Fischer L; Fuhrmann C; Hodler J
    Schweiz Med Wochenschr; 1973 Jan; 103(4):131-40. PubMed ID: 4683727
    [No Abstract]   [Full Text] [Related]  

  • 27. Dangerous duo--heart disease and kidney disease.
    Harv Heart Lett; 2003 Jul; 13(11):1-3. PubMed ID: 12888475
    [No Abstract]   [Full Text] [Related]  

  • 28. [Follow-up studies in recipients of cadaver kidney transplants].
    Scheitlin W; Brunner F; Moccetti T; Senning A
    Schweiz Med Wochenschr; 1968 May; 98(21):777-81. PubMed ID: 4882399
    [No Abstract]   [Full Text] [Related]  

  • 29. [Renal function in kidney donors, before and after unilateral nephrectomy].
    Ianhez LE; Sabbaga E; Kieffer J; Skromme G; de Campos-Freire JG
    Rev Paul Med; 1969 Nov; 75(5):275-80. PubMed ID: 4907299
    [No Abstract]   [Full Text] [Related]  

  • 30. Control of renal blood flow and sodium excretion in renal allografts by intrarenal infusion of acetylcholine.
    Kountz SL; Cochrum KC; Belzer FO
    Surg Forum; 1968; 19():210-2. PubMed ID: 4887909
    [No Abstract]   [Full Text] [Related]  

  • 31. Renal ageing.
    Martin JE; Sheaff MT
    J Pathol; 2007 Jan; 211(2):198-205. PubMed ID: 17200944
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone, phosphate and the kidney.
    Kleerekoper M; Bernstein RS; Rao DS; Frame B; Levin NW; Parfitt AM
    Prog Biochem Pharmacol; 1980; 17():190-8. PubMed ID: 6259656
    [No Abstract]   [Full Text] [Related]  

  • 33. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
    Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
    Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Scintigraphy on the function of transplanted kidneys].
    Pfeifer KJ; Rothe R; Ingrisch H; Edel HH; Pichlmaier H; Heinze HG
    Munch Med Wochenschr; 1973 Mar; 115(9):348-53. PubMed ID: 4632833
    [No Abstract]   [Full Text] [Related]  

  • 35. Targeting proteinuria as a valid surrogate for individualized kidney protective therapy.
    de Zeeuw D
    Am J Kidney Dis; 2008 May; 51(5):713-6. PubMed ID: 18436079
    [No Abstract]   [Full Text] [Related]  

  • 36. Ultrastructural analysis of the Fisher to Lewis rat model of chronic allograft nephropathy.
    Hamar P; Lipták P; Heemann U; Iványi B
    Transpl Int; 2005 Jul; 18(7):863-70. PubMed ID: 15948867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of chronic kidney disease based on estimated glomerular filtration rate and proteinuria in Icelandic adults.
    Viktorsdottir O; Palsson R; Andresdottir MB; Aspelund T; Gudnason V; Indridason OS
    Nephrol Dial Transplant; 2005 Sep; 20(9):1799-807. PubMed ID: 15928100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Utilization of human antilymphocyte horse globulins in treatment of primary nephrotic syndrome].
    Traeger J; Fries D; Carraz M; Blanc-Brunat N; Berhardt JP; Prévot C
    J Urol Nephrol (Paris); 1968 Sep; 74(9):695-703. PubMed ID: 4887793
    [No Abstract]   [Full Text] [Related]  

  • 39. Urine protein selectivity in human renal allografts.
    Braun WE; Merrill JP
    Transplantation; 1968 Nov; 6(8):867-78. PubMed ID: 4880325
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nephrology].
    Martin-Dupont C; Wone C; Aparicio M
    J Med Bord; 1966 Oct; 143(10):1609-14. PubMed ID: 4292349
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.